Manuscripts
Showing 1533 manuscripts.
Effect of low-dose ritonavir on the pharmacokinetics of the CXCR4 antagonist AMD070 in healthy volunteers
Citation
Ying-Jun Cao, Charles Flexner, Shelia B. Dunaway, Jeong-Gun Park, Karin L. Klingman, Ilene P. Wiggins, Jeanne Conley, Christine Radebaugh, Angela D.M. Kashuba, Ron T. MacFarland, Stephen L. Becker, Craig Hendrix. Effect of low-dose ritonavir on the pharmacokinetics of the CXCR4 antagonist AMD070 in healthy volunteers. Antimicrobial Agents and Chemotherapy. 2008. 52: 1630-4.Year
2008
Journal
Antimicrobial Agents and Chemotherapy
In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject
Citation
Athe Tsibris, Manish Sagar, Roy (Trip) Gulick, Zhaohui Su, Michael Hughes, Wayne Greaves, Mani Subramanian, Charles Flexner, Francoise Giguel, Kay E. Leopold, Eoin Coakley, Daniel R. Kuritzkes. In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject. Journal of Virology. 2008. 82: 8210¿14.Year
2008
Journal
Journal of Virology
In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients
Citation
Rana Traboulsi, Pranab K. Mukherjee, Mahmoud A. Ghannoum. In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients. International Journal of Antimicrobial Agents. 2008. 31: 272-6. PMID: 18242063Year
2008
Journal
International Journal of Antimicrobial Agents
Two-sample tests of area-under-the-curve in the presence of missing data
Citation
John Spritzler, Victor DeGruttola, Lixia Pei. Two-sample tests of area-under-the-curve in the presence of missing data. International Journal of Biostatistics. 2008. 4: 1-18.Year
2008
Journal
International Journal of Biostatistics
S-phase entry leads to cell death in circulating T cells from HIV-infected persons
Citation
Scott F. Sieg, Douglas A. Bazdar, Michael M. Lederman. S-phase entry leads to cell death in circulating T cells from HIV-infected persons. Journal of Leukocyte Biology. 2008. 83: 1-6.Year
2008
Journal
Journal of Leukocyte Biology
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy
Citation
Beverly E. Sha, Shurjeel Choudhri, Richard T. Davey, Peter Pertel, Alice Benson, Delanie J. Cassell, Brian Gazzard, Mark Holodniy, Jay Lalezari, Yves Levy, Ronald T. Mitsuyasu, Frank Palella, Richard B. Pollard, Prabhu Rajagopalan, Michael Switow Saag, Robert A. Salata. Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy. Journal of Interferon and Cytokine Research. 2008. 28: 89-100.Year
2008
Journal
Journal of Interferon and Cytokine Research
Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques
Citation
David M. Asmuth, Kristina Abel, Michael D. George, S. Dandekar, Richard B. Pollard, Chris Miller. Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques. Journal of Medical Primatology. 2008. 37: 26-30.Year
2008
Journal
Journal of Medical Primatology
In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits
Citation
Adriana Weinberg, John Spritzler, Mostafa Nokta, Rachel Schrier, Alan Landay, D. Brown, Richard B. Pollard. In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits. Clinical and Vaccine Immunology. 2008. 15: 1398-409.Year
2008
Journal
Clinical and Vaccine Immunology
Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infection
Citation
Joshua J. Minuto, Richard H. Haubrich. Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infection. Future HIV Therapy. 2008. 2: 525-37.Year
2008
Journal
Future HIV Therapy